Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    17179052 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease
Conditions: Fabry Disease;   Fabry´s Disease;   Anderson-Fabry Disease
Intervention:
2 Completed
Has Results
A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease
Condition: Fabry Disease
Interventions: Biological: Fabrazyme (agalsidase beta);   Biological: Placebo

Indicates status has not been verified in more than two years